Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Belgian group discloses novel treatments for neurodegenerative disorders

July 16, 2012

New D3/5-HT2A receptor modulators patented by Roche

July 16, 2012

Bracco designs novel vaccines for allergy

July 16, 2012

Japanese team discloses novel treatments for diabetes

July 16, 2012

New EFNA modulators designed by Stem CentRx

July 16, 2012

Bristol-Myers Squibb patents new agents for HIV infection

July 16, 2012

Researchers at Lycera prepare new F1F0 ATPase inhibitors

July 16, 2012

Novel mGlu5 receptor modulators patented by Vanderbilt University

July 13, 2012

U.S. group discloses novel nitroxide derivatives

July 13, 2012

Group at Nektar Therapeutics designs new analgesic agents

July 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026